FOLD Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own FOLD shares is 379, representing 103.91% of the company's common stock.

REDMILE GROUP, LLC, in the last quarter, reduced its stake in FOLD by -10.59% restricting it's holding to 13.26 million shares of worth nearly $156.17M. STATE STREET CORP also lessened -5.47% of the FOLD shares from its portfolio, reducing its holding to 12.44 million shares of worth $146.57M. MORGAN STANLEY also shunned FOLD shares holding by -27.18% last quarter which brought its holding to 9.7 million shares worth $114.32M.

As per its latest 13F filing, SATURN V CAPITAL MANAGEMENT LLC increased its stake in FOLD by 349.25% in the last quarter. The institutional holder raised its holding to 898.38 thousand shares having worth more than $10.58M. WELLINGTON MANAGEMENT GROUP LLP also added 23.79% more shares of FOLD to its portfolio, raising its holding to 18.8 million shares of worth $221.51M. JANUS HENDERSON GROUP PLC also increased its FOLD shares holding by 20.05% which brought its holding to 13.81 million shares worth $162.71M.

The insider with the most stakes in FOLD is Campbell Bradley L , President and CEO at the company. Additionally, FOLD stock is highly held by Executive Chairman Crowley John F and Chief Financial Officer Quimi Daphne among others.

Company executives, directors, and other insiders own 0.76% percent of Amicus Therapeutics, Inc.'s stock. Within the last six months, there have been 6 transaction(s) in which FOLD insiders have sold stock, totaling 45.4K shares. Insiders that have sold shares include CAMPBELL BRADLEY L, MCGLYNN MARGARET G, and CROWLEY JOHN F.

There have been 0 transaction(s) during the past 6-months in which Amicus Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 5.32M Amicus Therapeutics, Inc. shares are held by insiders, which represents about 0.76% of FOLD stock.

FOLD President and CEO, Campbell Bradley L holds the largest portfolio of the company's shares. FOLD shares owned by Campbell total nearly 886.65 thousand.

SATURN V CAPITAL MANAGEMENT LLC is the largest institutional owner in FOLD which holds 898.38 thousand shares worth $10.58M or 0.3% of the total FOLD shares outstanding followed by WELLINGTON MANAGEMENT GROUP LLP with ownership of 18.8 million shares representing 6.37% of the FOLD ownership. JANUS HENDERSON GROUP PLC is the third largest stakeholder with 13.81 million shares or 4.68% of the ownership worth more than $162.71M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the FOLD is concerned, it is a stock which is optionable.

Number of FOLD shares short is 19.36M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 298.81M shares of FOLD are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, FOLD has 241.08M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for FOLD is 7.32.